The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 30
- 30 new
- Median first-year cost
- $129,675
- $4,837,988 in all
- Institutions
- 27
- 29 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
10
10
10
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
- UT SOUTHWESTERN MEDICAL CENTER2
- VITALANT2
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- CORIELL INSTITUTE FOR MEDICAL RESEARCH1
and 22 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-K (J1))10
- Special Emphasis Panel (ZHL1 CSR-K (M1))10
- Special Emphasis Panel (ZHL1 CSR-B (M1))5
- Special Emphasis Panel (ZHL1 CSR-L (J1))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2025 | Defining Drivers of mtDNA Levels in Blood Components and Their Impact on Transfusion-Related Lung Injury1R21HL181073-01 | Norris, Philip J. | VITALANT, AZ | First-year cost $262,500 | Study section ZHL1 |
| FY2025 | Genetic Regulation of Gene Expression in Hispanic/Latino Cord Blood Samples1R21HL181171-01 | De Smith, Adam | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $262,159 | Study section ZHL1 |
| FY2025 | Mitochondrial Derived Peptides in Chronic Obstructive Pulmonary Disease1R21HL179368-01 | Kliment, Corrine R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $258,516 | Study section ZHL1 |
| FY2025 | Genetically Linked Metabolites of Sepsis Severity and Mortality1R21HL181071-01 | Shapiro, Nathan ISofer, TamarStringer, Kathleen A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $256,785 | Study section ZHL1 |
| FY2025 | Common and distinct metabolic pathways of pulmonary sarcoidosis phenotypes and endotypes1R21HL175174-01A1 | Liao, Shu-Yi | NATIONAL JEWISH HEALTH, CO | First-year cost $249,000 | Study section ZHL1 |
| FY2025 | Early, non-invasive detection of pulmonary vascular dysfunction in acute respiratory distress syndrome1R21HL175093-01A1 | Alba, George A | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $247,500 | Study section ZHL1 |
| FY2025 | Renin as a Predictive and Prognostic Biomarker in Sepsis-Induced Hypotension1R21HL179365-01 | Miano, Todd Anthony | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $243,750 | Study section ZHL1 |
| FY2025 | Association between blood biomarkers and adverse cardiovascular and kidney outcomes1R21HL181072-01 | Hedayati, Susan | STATE UNIVERSITY NEW YORK STONY BROOK, NY | First-year cost $237,750 | Study section ZHL1 |
| FY2025 | Circulating immunoactive small RNAs in COPD as biomarkers.1R21HL179322-01 | Shigematsu, Megumi Hamasaki | THOMAS JEFFERSON UNIVERSITY, PA | First-year cost $234,000 | Study section ZHL1 |
| FY2025 | iPSC-derived VSMC for high-throughput screening of small molecules for aortic aneurysm1R21HL173511-01A1 | Seta, Francesca | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $122,625 | Study section ZHL1 |
| FY2024 | Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists1R21HL175169-01 | Huang, JianKlein, Peter S | CORIELL INSTITUTE FOR MEDICAL RESEARCH, NJ | First-year cost $146,876 | Study section ZHL1 |
| FY2024 | Role of specialized pro-resolving mediators of inflammation resolution in emphysema: analyses of SPIROMICS and LEEP1R21HL175177-01 | Bose, SonaliHanson, Corrine K | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $139,088 | Study section ZHL1 |
| FY2024 | Chronic dehydration in sickle cell disease: An actionable biomarker to prevent vaso-occlusive episodes?1R21HL169555-01A1 | Karafin, Matthew SNovelli, Enrico M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $131,938 | Study section ZHL1 |
| FY2024 | Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository1R21HL175170-01 | Busch, Michael Paul | VITALANT, AZ | First-year cost $131,250 | Study section ZHL1 |
| FY2024 | Evaluating accessory cells to improve homing and engraftment efficiency of CD34+ cells from sickle cell disease patients1R21HL175096-01 | Shi, Patricia Ann | NEW YORK BLOOD CENTER, NY | First-year cost $128,100 | Study section ZHL1 |
| FY2024 | Multi-Omic Characterization of Immune Cells in Sarcoidosis1R21HL175092-01 | Montgomery, Courtney | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | First-year cost $127,875 | Study section ZHL1 |
| FY2024 | Local cellular communication networks in COPD endotypes1R21HL173512-01 | Sauler, Maor | YALE UNIVERSITY, CT | First-year cost $125,625 | Study section ZHL1 |
| FY2024 | Defining immune pathways involved in the formation of antibodies against factor VIII1R21HL173513-01 | Patel, Seema Rajnikant | EMORY UNIVERSITY, GA | First-year cost $117,375 | Study section ZHL1 |
| FY2024 | Lung deposition dose of black carbon as a driver of health Disparities1R21HL173388-01 | Leng, Shuguang | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | First-year cost $114,375 | Study section ZHL1 |
| FY2024 | Anandamide in blood pressure control1R21HL169709-01A1 | Klawitter, Jelena | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $94,500 | Study section ZHL1 |
| FY2023 | Cardiac biomarkers, intensive blood pressure treatment and risk of adverse cardiovascular outcomes in type 2 diabetes, a secondary analysis of the ACCORD BP1R21HL169708-01 | Pandey, Ambarish | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $136,437 | Study section ZHL1 |
| FY2023 | The role of alpha-aminoadipic acid (2-AAA) in residual CVD risk in T2D1R21HL169186-01 | Ferguson, Jane F | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $131,250 | Study section ZHL1 |
| FY2023 | Biomarkers of Kidney Secretory Function for Discriminating Risk of Hyperkalemia1R21HL169633-01 | Wettersten, Nicholas | VETERANS MEDICAL RESEARCH FDN/SAN DIEGO, CA | First-year cost $123,088 | Study section ZHL1 |
| FY2023 | Blood Biomarkers Associated with Adverse Outcomes in Heart Failure1R21HL168476-01 | Hedayati, SusanRoehm, Bethany | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $123,000 | Study section ZHL1 |
| FY2023 | Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial1R21HL169803-01 | Van Dam, Rob M. | GEORGE WASHINGTON UNIVERSITY, DC | First-year cost $121,125 | Study section ZHL1 |
| FY2023 | Precision Medicine for Nutrition in EDEN1R21HL168070-01 | Shah, Faraaz Ali | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $119,250 | Study section ZHL1 |
| FY2023 | Validation of a Genetic-based Biomarker Panel for Stratification of Mortality Risk in ARDS Patients1R21HL168142-01 | Bime, ChristianGarcia, Joe G. N. | UNIVERSITY OF ARIZONA, AZ | First-year cost $115,125 | Study section ZHL1 |
| FY2023 | The Role of Lipids in Obesity-mediated Protection in Sepsis1R21HL169804-01 | Shridas, PreethaStarr, Marlene Elena | UNIVERSITY OF KENTUCKY, KY | First-year cost $114,750 | Study section ZHL1 |
| FY2023 | IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease1R21HL167662-01 | Pandey, Janardan P | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | First-year cost $113,250 | Study section ZHL1 |
| FY2023 | PLA2R1 Loss-of-Function: A Monogenic Cause of Sarcoidosis in African-Americans in the ACCESS Cohort1R21HL168484-01 | Borza, Dorin-Bogdan | MEHARRY MEDICAL COLLEGE, TN | First-year cost $109,126 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.